Prevalence of Monoclonal Gammopathy of Undetermined Significance
Open Access
- 30 March 2006
- journal article
- research article
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 354 (13), 1362-1369
- https://doi.org/10.1056/nejmoa054494
Abstract
The prevalence of monoclonal gammopathy of undetermined significance (MGUS), a premalignant plasma-cell disorder, among persons 50 years of age or older has not been accurately determined. We used sensitive laboratory techniques to ascertain the prevalence of MGUS in a large population in a well-defined geographic area.Keywords
This publication has 18 references indexed in Scilit:
- Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significanceBlood, 2005
- Long-term Follow-up of 241 Patients With Monoclonal Gammopathy of Undetermined Significance: The Original Mayo Clinic Series 25 Years LaterMayo Clinic Proceedings, 2004
- Review of 1027 Patients With Newly Diagnosed Multiple MyelomaMayo Clinic Proceedings, 2003
- A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined SignificanceThe New England Journal of Medicine, 2002
- The Threat to Medical-Records ResearchThe New England Journal of Medicine, 1997
- Occurrence of monoclonal components in general practice: Clinical implicationsEuropean Journal of Haematology, 1992
- Laboratory investigation of monoclonal gammopathy during 10 years of screening in a general hospital.Journal of Clinical Pathology, 1987
- The Significance of Monoclonal Gammopathy in a Normal Population*Australian and New Zealand Journal of Medicine, 1971
- Frequency of Pathological Proteins (M‐components) in 6,995 Sera from an Adult PopulationActa Medica Scandinavica, 1966
- Frequency of “Abnormal” Serum Globulins (M‐Components) in the AgedActa Medica Scandinavica, 1963